These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationship of the subgingival microbiota to a chairside test for aspartate aminotransferase in gingival crevicular fluid. Wong MY; Lu CL; Liu CM; Hou LT; Chang WK J Periodontol; 1999 Jan; 70(1):57-62. PubMed ID: 10052771 [TBL] [Abstract][Full Text] [Related]
5. Effect of locally delivered minocycline microspheres on markers of bone resorption. Oringer RJ; Al-Shammari KF; Aldredge WA; Iacono VJ; Eber RM; Wang HL; Berwald B; Nejat R; Giannobile WV J Periodontol; 2002 Aug; 73(8):835-42. PubMed ID: 12211491 [TBL] [Abstract][Full Text] [Related]
6. [Gingival crevicular aspartate aminotransferase levels in periodontitis patients before and after periodontal treatment]. Li R Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Mar; 27(2):70-3, 127. PubMed ID: 1288991 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal evaluation of aspartate aminotransferase in the crevicular fluid of implants with bone loss and signs of progressive disease. Rühling A; Jepsen S; Kocher T; Plagmann HC Int J Oral Maxillofac Implants; 1999; 14(3):428-35. PubMed ID: 10379118 [TBL] [Abstract][Full Text] [Related]
8. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. Tüter G; Kurtiş B; Serdar M J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249 [TBL] [Abstract][Full Text] [Related]
9. Neutral proteases in crevicular fluid as an indicator for periodontal treatment intervention. Bader HI; Boyd RL Am J Dent; 2001 Oct; 14(5):314-8. PubMed ID: 11803997 [TBL] [Abstract][Full Text] [Related]
10. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis. Erdemir EO; Duran I; Haliloglu S J Clin Periodontol; 2004 Feb; 31(2):99-104. PubMed ID: 15016034 [TBL] [Abstract][Full Text] [Related]
11. A multi-center clinical trial of a new chairside test in distinguishing between diseased and healthy periodontal sites. II. Association between site type and test outcome before and after therapy. Magnusson I; Persson RG; Page RC; DeRouen TA; Crawford JM; Cohen RL; Chambers DA; Alves ME; Clark WB J Periodontol; 1996 Jun; 67(6):589-96. PubMed ID: 8794969 [TBL] [Abstract][Full Text] [Related]
12. Prediction and diagnosis of attachment loss by enhanced chemiluminescent assay of crevicular fluid alkaline phosphatase levels. Chapple IL; Garner I; Saxby MS; Moscrop H; Matthews JB J Clin Periodontol; 1999 Mar; 26(3):190-8. PubMed ID: 10100046 [TBL] [Abstract][Full Text] [Related]
13. Relationship between gingival crevicular fluid levels of aspartate aminotransferase and active tissue destruction in treated chronic periodontitis patients. Persson GR; DeRouen TA; Page RC J Periodontal Res; 1990 Mar; 25(2):81-7. PubMed ID: 2139121 [TBL] [Abstract][Full Text] [Related]
14. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. Nakamura T; Kido J; Kido R; Ohishi K; Yamauchi N; Kataoka M; Nagata T J Periodontol; 2000 Mar; 71(3):361-7. PubMed ID: 10776922 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. Alpagot T; Bell C; Lundergan W; Chambers DW; Rudin R J Clin Periodontol; 2001 Apr; 28(4):353-9. PubMed ID: 11314892 [TBL] [Abstract][Full Text] [Related]